Pharma Journalist -

Mesoblast Limited announced that the United States Food and Drug Administration’s (FDA) Office of Tissues and Advanced Therapies (OTAT) has granted Regenerative Medicine Advanced…
Read More...

Creative Medical Technology Holdings, Inc., a biotechnology company working to revolutionize care through the development of potentially best-in-class regenerative therapeutics,…
Read More...

Regeneron Pharmaceuticals, Inc.announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA (aflibercept) Injection to treat preterm infants with retinopathy of…
Read More...

ReviR Therapeutics, a privately held developer of a suite of small molecule RNA-targeting technologies for cancer and other genetically-defined diseases, and Asieris Pharmaceuticals, a…
Read More...

West Pharmaceutical Services, Inc. announces the expansion of its landmark collaboration with Corning Incorporated (NYSE: GLW), that now includes the exclusive distribution rights for…
Read More...

Syneos Health announced a strategic partnership with Haystack Health, a Roivant Health portfolio company developing advanced Artificial Intelligence (AI) and Natural Language Processing…
Read More...

Kiora Pharmaceuticals, Inc. announced it has received investigational new drug application approval for a Phase 2 study of KIO-101 for the treatment of the Ocular Presentation of…
Read More...

Vifor Fresenius Medical Care Renal Pharma (VFMCRP) announced the Therapeutic Goods Administration (TGA) in Australia has approved Tavneos in combination with a rituximab or…
Read More...

Forxiga (dapagliflozin) has been approved in the European Union to extend the indication for heart failure (HF) with reduced ejection fraction (HFrEF) to cover patients across the full…
Read More...

Aldeyra Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for topical ocular reproxalap, a first-in-class…
Read More...